NCT06285240: Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)
- State
- Completed
- Phase
- Phase 1
- People
- 28 taking part
- Started
- 28 Mar 2024
- Primary completion
- 23 Sep 2024
- Arms
- Panel A: MK-1167 + Donepezil 10mg QD, Panel B: MK-1167 6mg QD + Donepezil 10mg QD
- Results
- Posted on the registry
- 29 Feb 2024: Trial registered
- 28 Mar 2024: Trial started
- 23 Sep 2024: Trial completed
- 14 Oct 2025: Trial results posted